Darunavir Prezista once daily

Back to documents list

Monday 13th June 2011

Since the introduction of anti-retroviral drugs in 1996, their benefits in controlling HIV have been well documented. In line with current British HIV Association guidelines the SMC has approved Prezista in twice daily (600/100). Darunavir is an important option in the armoury of drugs currently available. Once a day administration is easier and more convenient.